Toleranzia is a research company focused on the development of drug candidates for the treatment of autoimmune diseases. The company has developed a platform technology focused on the muscular disease myasthenia gravis. In addition, the technology has been used in other areas such as diabetes and multiple sclerosis. Research collaboration is done together with external partners within the field. The head office is based in Gothenburg.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Flerie Invest AB | 58,05 | 58,05 | 2024-09-26 |
| Avanza Pension | 2,98 | 2,98 | 2024-09-26 |
| Nordnet Pensionsförsäkring | 2,92 | 2,92 | 2024-09-26 |
| Navcap AB | 1,21 | 1,21 | 2024-09-26 |
| Sören Christensen | 1,09 | 1,09 | 2024-09-26 |
| Jonas Ramstedt | 1,01 | 1,01 | 2024-09-26 |
| Nordea Liv & Pension | 0,88 | 0,88 | 2024-09-26 |
| Lars Molinder | 0,77 | 0,77 | 2024-09-26 |
| Mats Hansare | 0,70 | 0,70 | 2024-09-26 |
| Konstruktions o Försäljnings AB KFAB | 0,63 | 0,63 | 2024-09-26 |
